{"title":"BDS","markdown":{"yaml":{"engine":"knitr","title":"BDS"},"headingText":"What is BDS?","containsRefs":false,"markdown":"\n\n\n- **BDS** = Basic Data Structure\n- A flexible ADaM format used for most subject-level analysis datasets\n- Key features:\n  - One record per subject, parameter, and timepoint\n  - Standardized variables: `PARAMCD`, `AVAL`, `ADY`, `TRTP`, etc.\n  - Derived from SDTM + ADSL\n\n\n\n# BDS Subtypes - part 1\n\nBDS is used for different analysis goals:\n\n::: nonincremental\n\n| Subtype         | Purpose (in simple terms)                                                                 | Examples         |\n|-----------------|--------------------------------------------------------------------------------------------|------------------|\n| Findings        | For things we measure repeatedly during the study, like blood pressure or lab tests       | ADVS, ADLB, ADPC |\n| Exposure        | Describes what treatment the subject actually received — how much, how often, how long    | ADEX             |\n| Time-to-Event   | Tracks how long it takes for something important to happen (like death, relapse, etc.)    | ADTTE            |\n\n\n:::\n\n# BDS Subtypes - part2\n\nBDS is used for different analysis goals:\n\n::: nonincremental\n\n\n| Subtype         | Purpose (in simple terms)                                                                 | Examples         |\n|-----------------|--------------------------------------------------------------------------------------------|------------------|\n| Response        | Records the subject's response to treatment, usually as categories like \"improved\" or \"worsened\" | ADRS             |\n| PK Parameters   | Shows how the drug behaves in the body: absorption, concentration, elimination, etc.      | ADPPK            |\n\n\n:::\n\n\nAll share the same core structure, adapted for their purpose.\n\n\n\n# Common BDS Datasets\n\n## ADPC – Pharmacokinetics Concentrations\n\n- Based on SDTM PC (Pharmacokinetics Concentrations) domain  \n- Measures drug levels in biofluids (e.g. plasma)  \n- Used in non-compartmental PK analysis  \n\n\n## ADPPK – PK Parameters\n\n- Based on ADPC results  \n- Derived AUC (Area Under Curve), Cmax (Maximum Concentration), Tmax (Time to Max Concentration), etc.  \n- Used for dose-response modeling  \n\n\n## ADRS – Response Data\n\n- Derived from RS (Disease Response), TU (Tumor Identification), TR (Tumor Results) domains  \n- Categorical outcomes: CR (Complete Response), PR (Partial Response), SD (Stable Disease), PD (Progressive Disease)  \n- Often used in oncology  \n\n\n## ADTTE – Time to Event\n\n- Based on ADSL (Subject-Level) and AE (Adverse Events), DS (Disposition), VS (Vital Signs) events  \n- Used for endpoints like OS (Overall Survival), PFS (Progression-Free Survival), time to death  \n- Key variables: `AVAL`, `CNSR` (Censoring), `STARTDT`, `ADT` (Analysis Date)  \n\n\n## ADVS – Vital Signs\n\n- Based on SDTM VS (Vital Signs) domain  \n- Derives BMI (Body Mass Index), MAP (Mean Arterial Pressure), etc.  \n- Used in safety summaries  \n\n\n# Variable Types in BDS - part 1\n\nWe group derived variables by **purpose**:\n\n- Timing\n- Parameter Identification\n- Results\n- Derived Parameters\n- Reference Ranges\n\n# Variable Types in BDS - part 2\n\nWe group derived variables by **purpose**:\n\n- Baseline & Change\n- Flags\n- Treatment\n- Categorization\n- Criterion-Based Flags\n- Row creation / imputation\n\n\n## Timing Variables\n\nThese variables place each observation in the study timeline and help track when it occurred relative to treatment, visits, or other study milestones.\n\n::: nonincremental\n| Variable | Description | Why it's Needed |\n|----------|-------------|-----------------|\n| `ADT` | Analysis date | Anchors timepoint in study |\n| `ADTM` | Analysis datetime | Adds time granularity |\n| `ADY` | Relative study day | For analysis over time |\n:::\n\n\n## Timing Variables\n\nThese variables place each observation in the study timeline and help track when it occurred relative to treatment, visits, or other study milestones.\n\n::: nonincremental\n| Variable | Description | Why it's Needed |\n|----------|-------------|-----------------|\n| `ADTF`, `ATMF` | Imputation flags | Tracks incomplete dates |\n| `AVISIT`, `AVISITN` | Visit name/number | Sorting & summaries |\n| `APHASE`, `APERIOD` | Study phase/period | For grouping data |\n| `ONTRTFL` | On-treatment flag | Treatment window check |\n:::\n\n\n## Parameter Identification\n\nThese variables define what is being measured — each record in BDS must correspond to a unique parameter per subject per timepoint.\n\n::: nonincremental\n| Variable | Description |\n|----------|-------------|\n| `PARAMCD` | Short parameter code |\n| `PARAM` | Full parameter name |\n| `PARAMN` | Numeric ID (optional) |\n| `PARCAT1`, `PARCAT2` | Parameter categories |\n:::\n\n\n## Result Variables\n\nThese variables store the main output of analysis — either numeric results or their character equivalents and categorized forms.\n\n::: nonincremental\n| Variable | Description |\n|----------|-------------|\n| `AVAL` | Numeric result |\n| `AVALC` | Character result |\n| `AVALCATy` | Categorization (e.g. low/normal/high) |\n:::\n\n\n## Derived Parameters\n\nUsed to compute secondary or composite measurements derived from primary variables, such as BMI or MAP.\n\n::: nonincremental\n| Variable | Description |\n|----------|-------------|\n| `BMI`, `MAP`, etc. | Derived from base measurements |\n:::\n\n\n## Reference Ranges\n\nThese help classify whether values are within normal clinical limits, often based on lab ranges.\n\n::: nonincremental\n| Variable | Description |\n|----------|-------------|\n| `ANRLO`, `ANRHI` | Normal limits |\n| `ANRIND` | Low/High/Normal flag |\n| `BNRIND` | Baseline version of ANRIND |\n:::\n\n\n## Baseline & Change\n\nThese variables allow comparison of on-treatment values to a defined pre-treatment baseline.\n\n::: nonincremental\n| Variable | Description |\n|----------|-------------|\n| `BASE` | Baseline value |\n| `CHG` | Change from baseline |\n| `PCHG` | Percent change |\n| `ABLFL` | Baseline flag |\n| `BASETYPE` | Type of baseline measurement |\n:::\n\n\n## Flags & Filtering\n\nBinary flags are used to identify records relevant to specific analyses or TLGs.\n\n::: nonincremental\n| Variable | Description |\n|----------|-------------|\n| `ANL01FL` | Primary analysis record flag |\n| `ASEQ` | Sequence number |\n:::\n\n\n## Treatment Assignment\n\nUsed to categorize subjects by planned and actual treatment arms.\n\n::: nonincremental\n| Variable | Description |\n|----------|-------------|\n| `TRTA` | Actual treatment |\n| `TRTP` | Planned treatment |\n:::\n\n\n## Categorization & Criteria\n\nUsed to apply clinical cutoffs or create groupings based on results.\n\n::: nonincremental\n| Variable | Description |\n|----------|-------------|\n| `AVALCATy` | Categorized values |\n| `CRITy`, `CRITyFL`, `CRITyFN` | Threshold logic (e.g., BP > 180) |\n:::\n\n\n## ADSL Merge & New Rows\n\nDerived BDS datasets also pull in subject-level attributes from ADSL, and may create new rows summarizing or imputing data.\n\n- Add subject-level variables from ADSL (e.g. `AGE`, `SEX`, `TRTSDT`)\n- Derive new records (e.g. summary rows, worst value, average across visits)\n\n\n# Hands-On Workshop: BDS – Findings\n\nWe will derive a BDS Findings dataset using `{admiral}`.\n\nLink: [https://pharmaverse.github.io/admiral/articles/bds_finding.html](https://pharmaverse.github.io/admiral/articles/bds_finding.html)\n\nKey steps:\n- Read SDTM data\n- Derive `ADT`, `ADY`\n- Assign `PARAMCD`, `PARAM`\n- Derive `AVAL`, `BASE`, `CHG`, `ANL01FL`, etc.\n- Merge with ADSL\n- Add labels and attributes\n\nRepository: [GitHub Code](https://github.com/pharmaverse/admiral/blob/main/vignettes/bds_finding.Rmd)\n\n\n\n# Other BDS Types Work Similarly\n\nOnce you master Findings-type BDS, the rest follow similar logic:\n\n- TTE: uses `CNSR`, event definitions\n- Exposure: aggregates dose/duration from EX\n\nFurther examples:\n- [Time-to-Event BDS (ADTTE)](https://pharmaverse.github.io/admiral/cran-release/articles/bds_tte.html)\n- [Exposure BDS](https://pharmaverse.github.io/admiral/articles/bds_exposure.html)\n\n\n\n# Questions?\n","srcMarkdownNoYaml":"\n\n# What is BDS?\n\n- **BDS** = Basic Data Structure\n- A flexible ADaM format used for most subject-level analysis datasets\n- Key features:\n  - One record per subject, parameter, and timepoint\n  - Standardized variables: `PARAMCD`, `AVAL`, `ADY`, `TRTP`, etc.\n  - Derived from SDTM + ADSL\n\n\n\n# BDS Subtypes - part 1\n\nBDS is used for different analysis goals:\n\n::: nonincremental\n\n| Subtype         | Purpose (in simple terms)                                                                 | Examples         |\n|-----------------|--------------------------------------------------------------------------------------------|------------------|\n| Findings        | For things we measure repeatedly during the study, like blood pressure or lab tests       | ADVS, ADLB, ADPC |\n| Exposure        | Describes what treatment the subject actually received — how much, how often, how long    | ADEX             |\n| Time-to-Event   | Tracks how long it takes for something important to happen (like death, relapse, etc.)    | ADTTE            |\n\n\n:::\n\n# BDS Subtypes - part2\n\nBDS is used for different analysis goals:\n\n::: nonincremental\n\n\n| Subtype         | Purpose (in simple terms)                                                                 | Examples         |\n|-----------------|--------------------------------------------------------------------------------------------|------------------|\n| Response        | Records the subject's response to treatment, usually as categories like \"improved\" or \"worsened\" | ADRS             |\n| PK Parameters   | Shows how the drug behaves in the body: absorption, concentration, elimination, etc.      | ADPPK            |\n\n\n:::\n\n\nAll share the same core structure, adapted for their purpose.\n\n\n\n# Common BDS Datasets\n\n## ADPC – Pharmacokinetics Concentrations\n\n- Based on SDTM PC (Pharmacokinetics Concentrations) domain  \n- Measures drug levels in biofluids (e.g. plasma)  \n- Used in non-compartmental PK analysis  \n\n\n## ADPPK – PK Parameters\n\n- Based on ADPC results  \n- Derived AUC (Area Under Curve), Cmax (Maximum Concentration), Tmax (Time to Max Concentration), etc.  \n- Used for dose-response modeling  \n\n\n## ADRS – Response Data\n\n- Derived from RS (Disease Response), TU (Tumor Identification), TR (Tumor Results) domains  \n- Categorical outcomes: CR (Complete Response), PR (Partial Response), SD (Stable Disease), PD (Progressive Disease)  \n- Often used in oncology  \n\n\n## ADTTE – Time to Event\n\n- Based on ADSL (Subject-Level) and AE (Adverse Events), DS (Disposition), VS (Vital Signs) events  \n- Used for endpoints like OS (Overall Survival), PFS (Progression-Free Survival), time to death  \n- Key variables: `AVAL`, `CNSR` (Censoring), `STARTDT`, `ADT` (Analysis Date)  \n\n\n## ADVS – Vital Signs\n\n- Based on SDTM VS (Vital Signs) domain  \n- Derives BMI (Body Mass Index), MAP (Mean Arterial Pressure), etc.  \n- Used in safety summaries  \n\n\n# Variable Types in BDS - part 1\n\nWe group derived variables by **purpose**:\n\n- Timing\n- Parameter Identification\n- Results\n- Derived Parameters\n- Reference Ranges\n\n# Variable Types in BDS - part 2\n\nWe group derived variables by **purpose**:\n\n- Baseline & Change\n- Flags\n- Treatment\n- Categorization\n- Criterion-Based Flags\n- Row creation / imputation\n\n\n## Timing Variables\n\nThese variables place each observation in the study timeline and help track when it occurred relative to treatment, visits, or other study milestones.\n\n::: nonincremental\n| Variable | Description | Why it's Needed |\n|----------|-------------|-----------------|\n| `ADT` | Analysis date | Anchors timepoint in study |\n| `ADTM` | Analysis datetime | Adds time granularity |\n| `ADY` | Relative study day | For analysis over time |\n:::\n\n\n## Timing Variables\n\nThese variables place each observation in the study timeline and help track when it occurred relative to treatment, visits, or other study milestones.\n\n::: nonincremental\n| Variable | Description | Why it's Needed |\n|----------|-------------|-----------------|\n| `ADTF`, `ATMF` | Imputation flags | Tracks incomplete dates |\n| `AVISIT`, `AVISITN` | Visit name/number | Sorting & summaries |\n| `APHASE`, `APERIOD` | Study phase/period | For grouping data |\n| `ONTRTFL` | On-treatment flag | Treatment window check |\n:::\n\n\n## Parameter Identification\n\nThese variables define what is being measured — each record in BDS must correspond to a unique parameter per subject per timepoint.\n\n::: nonincremental\n| Variable | Description |\n|----------|-------------|\n| `PARAMCD` | Short parameter code |\n| `PARAM` | Full parameter name |\n| `PARAMN` | Numeric ID (optional) |\n| `PARCAT1`, `PARCAT2` | Parameter categories |\n:::\n\n\n## Result Variables\n\nThese variables store the main output of analysis — either numeric results or their character equivalents and categorized forms.\n\n::: nonincremental\n| Variable | Description |\n|----------|-------------|\n| `AVAL` | Numeric result |\n| `AVALC` | Character result |\n| `AVALCATy` | Categorization (e.g. low/normal/high) |\n:::\n\n\n## Derived Parameters\n\nUsed to compute secondary or composite measurements derived from primary variables, such as BMI or MAP.\n\n::: nonincremental\n| Variable | Description |\n|----------|-------------|\n| `BMI`, `MAP`, etc. | Derived from base measurements |\n:::\n\n\n## Reference Ranges\n\nThese help classify whether values are within normal clinical limits, often based on lab ranges.\n\n::: nonincremental\n| Variable | Description |\n|----------|-------------|\n| `ANRLO`, `ANRHI` | Normal limits |\n| `ANRIND` | Low/High/Normal flag |\n| `BNRIND` | Baseline version of ANRIND |\n:::\n\n\n## Baseline & Change\n\nThese variables allow comparison of on-treatment values to a defined pre-treatment baseline.\n\n::: nonincremental\n| Variable | Description |\n|----------|-------------|\n| `BASE` | Baseline value |\n| `CHG` | Change from baseline |\n| `PCHG` | Percent change |\n| `ABLFL` | Baseline flag |\n| `BASETYPE` | Type of baseline measurement |\n:::\n\n\n## Flags & Filtering\n\nBinary flags are used to identify records relevant to specific analyses or TLGs.\n\n::: nonincremental\n| Variable | Description |\n|----------|-------------|\n| `ANL01FL` | Primary analysis record flag |\n| `ASEQ` | Sequence number |\n:::\n\n\n## Treatment Assignment\n\nUsed to categorize subjects by planned and actual treatment arms.\n\n::: nonincremental\n| Variable | Description |\n|----------|-------------|\n| `TRTA` | Actual treatment |\n| `TRTP` | Planned treatment |\n:::\n\n\n## Categorization & Criteria\n\nUsed to apply clinical cutoffs or create groupings based on results.\n\n::: nonincremental\n| Variable | Description |\n|----------|-------------|\n| `AVALCATy` | Categorized values |\n| `CRITy`, `CRITyFL`, `CRITyFN` | Threshold logic (e.g., BP > 180) |\n:::\n\n\n## ADSL Merge & New Rows\n\nDerived BDS datasets also pull in subject-level attributes from ADSL, and may create new rows summarizing or imputing data.\n\n- Add subject-level variables from ADSL (e.g. `AGE`, `SEX`, `TRTSDT`)\n- Derive new records (e.g. summary rows, worst value, average across visits)\n\n\n# Hands-On Workshop: BDS – Findings\n\nWe will derive a BDS Findings dataset using `{admiral}`.\n\nLink: [https://pharmaverse.github.io/admiral/articles/bds_finding.html](https://pharmaverse.github.io/admiral/articles/bds_finding.html)\n\nKey steps:\n- Read SDTM data\n- Derive `ADT`, `ADY`\n- Assign `PARAMCD`, `PARAM`\n- Derive `AVAL`, `BASE`, `CHG`, `ANL01FL`, etc.\n- Merge with ADSL\n- Add labels and attributes\n\nRepository: [GitHub Code](https://github.com/pharmaverse/admiral/blob/main/vignettes/bds_finding.Rmd)\n\n\n\n# Other BDS Types Work Similarly\n\nOnce you master Findings-type BDS, the rest follow similar logic:\n\n- TTE: uses `CNSR`, event definitions\n- Exposure: aggregates dose/duration from EX\n\nFurther examples:\n- [Time-to-Event BDS (ADTTE)](https://pharmaverse.github.io/admiral/cran-release/articles/bds_tte.html)\n- [Exposure BDS](https://pharmaverse.github.io/admiral/articles/bds_exposure.html)\n\n\n\n# Questions?\n"},"formats":{"revealjs":{"identifier":{"display-name":"RevealJS","target-format":"revealjs","base-format":"revealjs"},"execute":{"fig-width":10,"fig-height":5,"fig-format":"retina","fig-dpi":96,"df-print":"default","error":false,"eval":false,"cache":null,"freeze":false,"echo":true,"output":true,"warning":false,"include":true,"keep-md":false,"keep-ipynb":false,"ipynb":null,"enabled":null,"daemon":null,"daemon-restart":false,"debug":false,"ipynb-filters":[],"ipynb-shell-interactivity":null,"plotly-connected":true,"engine":"knitr"},"render":{"keep-tex":false,"keep-typ":false,"keep-source":false,"keep-hidden":false,"prefer-html":false,"output-divs":true,"output-ext":"html","fig-align":"default","fig-pos":null,"fig-env":null,"code-fold":"none","code-overflow":"scroll","code-link":false,"code-line-numbers":true,"code-tools":false,"tbl-colwidths":"auto","merge-includes":true,"inline-includes":false,"preserve-yaml":false,"latex-auto-mk":true,"latex-auto-install":true,"latex-clean":true,"latex-min-runs":1,"latex-max-runs":10,"latex-makeindex":"makeindex","latex-makeindex-opts":[],"latex-tlmgr-opts":[],"latex-input-paths":[],"latex-output-dir":null,"link-external-icon":false,"link-external-newwindow":true,"self-contained-math":false,"format-resources":[]},"pandoc":{"standalone":true,"wrap":"none","default-image-extension":"png","html-math-method":{"method":"mathjax","url":"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.9/MathJax.js?config=TeX-AMS_HTML-full"},"slide-level":2,"to":"revealjs","incremental":false,"output-file":"BDS.html"},"language":{"toc-title-document":"Table of contents","toc-title-website":"On this page","related-formats-title":"Other Formats","related-notebooks-title":"Notebooks","source-notebooks-prefix":"Source","other-links-title":"Other Links","code-links-title":"Code Links","launch-dev-container-title":"Launch Dev Container","launch-binder-title":"Launch Binder","article-notebook-label":"Article Notebook","notebook-preview-download":"Download Notebook","notebook-preview-download-src":"Download Source","notebook-preview-back":"Back to Article","manuscript-meca-bundle":"MECA Bundle","section-title-abstract":"Abstract","section-title-appendices":"Appendices","section-title-footnotes":"Footnotes","section-title-references":"References","section-title-reuse":"Reuse","section-title-copyright":"Copyright","section-title-citation":"Citation","appendix-attribution-cite-as":"For attribution, please cite this work as:","appendix-attribution-bibtex":"BibTeX citation:","appendix-view-license":"View License","title-block-author-single":"Author","title-block-author-plural":"Authors","title-block-affiliation-single":"Affiliation","title-block-affiliation-plural":"Affiliations","title-block-published":"Published","title-block-modified":"Modified","title-block-keywords":"Keywords","callout-tip-title":"Tip","callout-note-title":"Note","callout-warning-title":"Warning","callout-important-title":"Important","callout-caution-title":"Caution","code-summary":"Code","code-tools-menu-caption":"Code","code-tools-show-all-code":"Show All Code","code-tools-hide-all-code":"Hide All Code","code-tools-view-source":"View Source","code-tools-source-code":"Source Code","tools-share":"Share","tools-download":"Download","code-line":"Line","code-lines":"Lines","copy-button-tooltip":"Copy to Clipboard","copy-button-tooltip-success":"Copied!","repo-action-links-edit":"Edit this page","repo-action-links-source":"View source","repo-action-links-issue":"Report an issue","back-to-top":"Back to top","search-no-results-text":"No results","search-matching-documents-text":"matching documents","search-copy-link-title":"Copy link to search","search-hide-matches-text":"Hide additional matches","search-more-match-text":"more match in this document","search-more-matches-text":"more matches in this document","search-clear-button-title":"Clear","search-text-placeholder":"","search-detached-cancel-button-title":"Cancel","search-submit-button-title":"Submit","search-label":"Search","toggle-section":"Toggle section","toggle-sidebar":"Toggle sidebar navigation","toggle-dark-mode":"Toggle dark mode","toggle-reader-mode":"Toggle reader mode","toggle-navigation":"Toggle navigation","crossref-fig-title":"Figure","crossref-tbl-title":"Table","crossref-lst-title":"Listing","crossref-thm-title":"Theorem","crossref-lem-title":"Lemma","crossref-cor-title":"Corollary","crossref-prp-title":"Proposition","crossref-cnj-title":"Conjecture","crossref-def-title":"Definition","crossref-exm-title":"Example","crossref-exr-title":"Exercise","crossref-ch-prefix":"Chapter","crossref-apx-prefix":"Appendix","crossref-sec-prefix":"Section","crossref-eq-prefix":"Equation","crossref-lof-title":"List of Figures","crossref-lot-title":"List of Tables","crossref-lol-title":"List of Listings","environment-proof-title":"Proof","environment-remark-title":"Remark","environment-solution-title":"Solution","listing-page-order-by":"Order By","listing-page-order-by-default":"Default","listing-page-order-by-date-asc":"Oldest","listing-page-order-by-date-desc":"Newest","listing-page-order-by-number-desc":"High to Low","listing-page-order-by-number-asc":"Low to High","listing-page-field-date":"Date","listing-page-field-title":"Title","listing-page-field-description":"Description","listing-page-field-author":"Author","listing-page-field-filename":"File Name","listing-page-field-filemodified":"Modified","listing-page-field-subtitle":"Subtitle","listing-page-field-readingtime":"Reading Time","listing-page-field-wordcount":"Word Count","listing-page-field-categories":"Categories","listing-page-minutes-compact":"{0} min","listing-page-category-all":"All","listing-page-no-matches":"No matching items","listing-page-words":"{0} words","listing-page-filter":"Filter","draft":"Draft"},"metadata":{"lang":"en","fig-responsive":false,"quarto-version":"1.7.32","auto-stretch":true,"knitr":{"opts_chunk":{"comment":"#>"}},"theme":["dark","custom.scss"],"footer":"<a href=\"/\" target=\"pharmaverse_club-index\">DSLC.io/pharmaexamples</a> | <a href=\"https://DSLC.io\" target=\"_blank\">DSLC.io</a>","transition":"slide","title":"BDS"}}},"projectFormats":["html"]}